Related Experiment Video
Updated: Jan 30, 2026

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
Published on: November 14, 2014
Identification of Pak1 inhibitors using water thermodynamic analysis
Jayashree Biswal1, Prajisha Jayaprakash1, Rayala Suresh Kumar2
1Department of Bioinformatics, Science Block Alagappa University, Karaikudi Tamil Nadu, India.
Abstract:
p21-activated kinases (Paks) play an integral component in various cellular diverse processes. The full activation of Pak is dependent upon several serine residues present in the N-terminal region, a threonine present at the activation loop, and finally the phosphorylation of these residues ensure the complete activation of Pak1. The present study deals with the identification of novel potent candidates of Pak1 using computational methods as anti-cancer compounds. A diverse energy based pharmacophore (e-pharmacophore) was developed using four co-crystal inhibitors of Pak1 having pharmacophore features of 5 (DRDRR), 6 (DRHADR), and 7 (RRARDRP and DRRDADH) hypotheses. These models were used for rigorous screening against e-molecule database. The obtained hits were filtered using ADME/T and molecular docking to identify the high affinity binders. These hits were subjected to hierarchical clustering using dendritic fingerprint inorder to identify structurally diverse molecules. The diverse hits were scored against generated water maps to obtain WM/MM ΔG binding energy. Furthermore, molecular dynamics simulation and density functional theory calculations were performed on the final hits to understand the stability of the complexes. Five structurally diverse novel Pak1 inhibitors (4835785, 32198676, 32407813, 76038049, and 32945545) were obtained from virtual screening, water thermodynamics and WM/MM ΔG binding energy. All hits revealed similar mode of binding pattern with the hinge region residues replacing the unstable water molecules in the binding site. The obtained novel hits could be used as a platform to design potent drugs that could be experimentally tested against cancer patients having increased Pak1 expression.
Insights
Computational methods identified novel p21-activated kinase (Pak1) inhibitors for anti-cancer drug development. These potent compounds show promise for targeting cancers with increased Pak1 expression.
Area of Science:
- Biochemistry
- Computational Chemistry
- Pharmacology
Background:
- p21-activated kinases (Paks) are crucial in cellular processes.
- Pak1 activation requires specific phosphorylation events.
- Dysregulated Pak1 is implicated in cancer development.
Purpose of the Study:
- To identify novel, potent Pak1 inhibitors using computational approaches.
- To discover potential anti-cancer drug candidates targeting Pak1.
Main Methods:
- Developed an energy-based pharmacophore model for Pak1 inhibitors.
- Screened a large database against the pharmacophore model.
- Filtered hits using ADME/T, molecular docking, and binding energy calculations.
- Validated stability using molecular dynamics and DFT.
Main Results:
- Identified five structurally diverse, novel Pak1 inhibitors.
- All identified inhibitors demonstrated a similar binding pattern in the hinge region.
- Inhibitors showed potential to displace water molecules in the binding site.
Conclusions:
- The identified compounds serve as a foundation for developing new anti-cancer drugs.
- These novel inhibitors warrant experimental validation for efficacy in Pak1-expressing cancers.
Related Concept Videos
Second Law of Thermodynamics
Second Law of Thermodynamics
Third Law of Thermodynamics
First Law of Thermodynamics
First Law of Thermodynamics
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

